Related references
Note: Only part of the references are listed.Importance of Safety in the Management of Osteoarthritis and the Need for Updated Meta-Analyses and Recommendations for Reporting of Harms FOREWORD
Jean-Yves Reginster et al.
DRUGS & AGING (2019)
Effects of flavoring compounds used in electronic cigarette refill liquids on endothelial and vascular function
Gerald Woelkart et al.
PLOS ONE (2019)
Cyclooxygenase-2 in cancer: A review
Nasser Hashemi Goradel et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Can NO-indomethacin counteract the topical gastric toxicity induced by indomethacin interactions with phospholipid bilayers?
Catarina Pereira-Leite et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2018)
Respiratory Tract Infections, Nonsteroidal Antiinflammatory Drugs and Acute Myocardial Infarction: Is Understanding Interaction Between Risk Factors the Key to Personalizing Prevention?
Charlotte Warren-Gash et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Cardioprotective effects of 5-hydroxymethylfurfural mediated by inhibition of L-type Ca2+ currents
G. Woelkart et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Synthesis and biological evaluation of fluorinated 1,5-diarylpyrrole-3-alkoxyethyl ether derivatives as selective COX-2 inhibitors endowed with anti-inflammatory activity
Angela Di Capua et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Crystal structure refinement with SHELXL
George M. Sheldrick
ACTA CRYSTALLOGRAPHICA SECTION C-STRUCTURAL CHEMISTRY (2015)
Development of a chitosan-derivative micellar formulation to improve celecoxib solubility and bioavailability
Natascia Mennini et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2014)
Non-steroidal anti-inflammatory drugs for lower urinary tract symptoms in benign prostatic hyperplasia: systematic review and meta-analysis of randomized controlled trials
Arman Kahokehr et al.
BJU INTERNATIONAL (2013)
Antiproliferative effect of two novel COX-2 inhibitors on human keratinocytes
Claudia Sticozzi et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Novel Analgesic/Anti-Inflammatory Agents: 1,5-Diarylpyrrole Nitrooxyalkyl Ethers and Related Compounds as Cyclooxygenase-2 Inhibiting Nitric Oxide Donors
Maurizio Anzini et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
The novel anti-inflammatory agent VA694, endowed with both NO-releasing and COX2-selective inhibiting properties, exhibits NO-mediated positive effects on blood pressure, coronary flow and endothelium in an experimental model of hypertension and endothelial dysfunction
A. Martelli et al.
PHARMACOLOGICAL RESEARCH (2013)
Novel Analgesic/Anti-Inflammatory Agents: Diarylpyrrole Acetic Esters Endowed with Nitric Oxide Releasing Properties
Mariangela Biava et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Cyclooxygenase Inhibitors: Scope of Their Use and Development in Cancer Chemotherapy
Mohammed Naseer A. Khan et al.
MEDICINAL RESEARCH REVIEWS (2011)
Naproxcinod, a new cyclooxygenase-inhibiting nitric oxide donator (CINOD)
Piet Geusens
EXPERT OPINION ON BIOLOGICAL THERAPY (2009)
Synthesis, biological evaluation, and enzyme docking simulations of 1,5-diarylpyrrole-3-alkoxyethyl ethers as selective cyclooxygenase-2 inhibitors endowed with anti-inflammatory and antinociceptive activity
Maurizio Anzini et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Cardiovascular events associated with rofecoxib: final analysis of the APPROVe trial
John A. Baron et al.
LANCET (2008)
A short history of SHELX
George M. Sheldrick
ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES (2008)
Withdrawal of COX-2 selective inhibitors rofecoxib and valdecoxib: impact on NSAID and gastroprotective drug prescribing and utilization
Shawn X. Sun et al.
CURRENT MEDICAL RESEARCH AND OPINION (2007)
Cardiovascular risk and inhibition of cyclooxygenase - A systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase
Patricia McGettigan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Novel nonsteroidal antiinflammatory drugs possessing a nitric oxide donor diazen-1-ium-1,2-diolate moiety:: Design, synthesis, biological evaluation, and nitric oxide release studies
C Velázquez et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
1,5-diarylpyrrole-3-acetic acids and esters as novel classes of potent and highly selective cyclooxygenase-2 inhibitors
M Biava et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Adverse cardiovascular effects of the coxibs
JM Dogné et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
The therapeutic potential of NO-NSAIDs
JL Wallace et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2003)
The inhibitory effect of propolis and caffeic acid phenethyl ester on cyclooxygenase activity in J774 macrophages
A Rossi et al.
PHYTOMEDICINE (2002)
Utility of metabolic stability screening:: comparison of in vitro and in vivo clearance
SE Clarke et al.
XENOBIOTICA (2001)
Share Paper
